Jonathan Gilroy
About Jonathan Gilroy
Jonathan Gilroy is a Principal Scientist in Analytical Development at Aimmune Therapeutics, with extensive experience in biotherapeutics characterization and strong laboratory skills in mass spectrometry, chromatography, and electrophoresis.
Work at Aimmune Therapeutics
Jonathan Gilroy currently serves as Principal Scientist in Analytical Development at Aimmune Therapeutics. He has held this position since 2021, contributing to the analytical development of biotherapeutics. His role involves the characterization of complex biological drugs, which is essential for ensuring their safety and efficacy.
Previous Experience at Aptevo Therapeutics
Prior to his current role, Jonathan worked as a Senior Scientist at Aptevo Therapeutics Inc from 2017 to 2019. During his time there, he focused on analytical development, further enhancing his expertise in biotherapeutics and contributing to the development of innovative therapies.
Background in Biotechnology
Jonathan has extensive experience in the biotechnology sector, having worked at Seattle Genetics as a Scientist from 2008 to 2017. His work involved the analysis and characterization of biotherapeutics, including monoclonal antibodies and antibody-drug conjugates, which are critical in modern therapeutic strategies.
Education and Expertise
Jonathan holds a Bachelor of Science degree in Chemistry from George Fox University. His educational background supports his strong laboratory skills in mass spectrometry, chromatography, and electrophoresis, which are vital for analytical development in the biotechnology field.
Diverse Professional Experience
Throughout his career, Jonathan has accumulated diverse experience in various roles. He worked as a CMC Technical Writer & Consultant at Global Regulatory Writing & Consulting, Inc. from 2019 to 2021, and as an Analyst at Bioanalytical Systems, Inc. from 1998 to 2006. He also held a position as a QC Associate at Bayer from 2006 to 2008, further broadening his expertise in the field.